New developments in antitumor anthracyclines

Pharmacology & Therapeutics
F ArcamoneF Zunino

Abstract

Doxorubicin is a major anticancer agent introduced to extended clinical use in the early 1970s. The fulfillment of a wide program of analogue synthesis led to the development of the better tolerated epirubicin and of a highly potent antileukemic drug, idarubicin. In recent years, on the basis of the available information on the molecular requirements for action, a new synthetic program, coupled with target-oriented pharmacological experiments, was carried out. Various interesting derivatives, namely, the 8- and 10-fluoro compounds and the disaccharides, were obtained. The latter compounds exhibited a strong dependence of biological activity on the orientation (axial vs. equatorial) of the second sugar moiety, daunosamine. A member of this group, namely, 7-O-(4'-O-alpha-L-daunosaminyl-2'-deoxy-alpha-L-fucosyl)-4-demetho xy-adriamycinone, is presently undergoing clinical trials as a third generation antitumor anthracycline.

Citations

Sep 6, 2013·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Tun-Chieh ChenYen-Hsu Chen
Jun 17, 2008·Applied Microbiology and Biotechnology·Andriy LuzhetskyyAndreas Bechthold
Aug 25, 2001·Biomaterials·K H BouhadirD J Mooney
Sep 23, 2003·Journal of Controlled Release : Official Journal of the Controlled Release Society·Jacques H Poupaert, Patrick Couvreur
Aug 30, 2001·European Journal of Medicinal Chemistry·C Monneret
Sep 6, 2002·Bioorganic & Medicinal Chemistry·Luigi MessoriCristina Di Bugno
Nov 5, 2002·Bioorganic & Medicinal Chemistry·Shu-Jia ZhangYan-Guang Wang
Jun 25, 1982·Nucleic Acids Research·M ManfaitT Theophanides
Sep 15, 2010·Antimicrobial Agents and Chemotherapy·Suzanne J F KapteinJohan Neyts
Sep 1, 1980·Antimicrobial Agents and Chemotherapy·J C McGuireR J White
Jul 9, 2008·European Journal of Pharmacology·Yevhen FilyakRostyslav Stoika
Nov 30, 2011·Drug Development and Industrial Pharmacy·Anna KrauseMałgorzata Wąsowska
May 16, 2007·Expert Opinion on Investigational Drugs·Felix Kratz
Nov 8, 2005·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Aristarchos PapagiannarosCostas Demetzos
Nov 30, 2010·Journal of Pharmaceutical and Biomedical Analysis·Agnieszka SobczakIrena Oszczapowicz
Mar 21, 2006·Research in Microbiology·Hao Jiang, C Richard Hutchinson
Oct 23, 2002·Molecular Pharmacology·Michaël FacompreChristian Bailly
May 14, 2004·Environmental and Molecular Mutagenesis·Mauricio LehmannHeloísa Helena Rodrigues de Andrade
Dec 14, 2011·Chembiochem : a European Journal of Chemical Biology·Xiaohui YanAndreas Bechthold
Feb 2, 2012·Journal of Biomolecular Structure & Dynamics·Shirlene Jackson Beckford, Dabney W Dixon
Jul 1, 1999·Molecular Pharmacology·F GuanoG Capranico
Jun 10, 2011·Photochemical & Photobiological Sciences : Official Journal of the European Photochemistry Association and the European Society for Photobiology·Ilse ManetSandra Monti
Apr 1, 2018·Applied Microbiology and Biotechnology·Nguyen Huy ThuanJae Kyung Sohng
Jan 24, 2013·Physical Chemistry Chemical Physics : PCCP·Pascale Changenet-BarretSandra Monti
Aug 19, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Clemens UngerKlaus Mross
May 24, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Eric SanchezJames R Berenson
May 22, 2019·Seminars in Cell & Developmental Biology·Tânia CapelôaPierre Sonveaux
Jul 5, 2008·The Journal of Physical Chemistry. a·Andrzej Nowacki, Beata Liberek

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.